Alpha Radiation Emitters Device (DaRT) for the Treatment of Non-Metastatic Locally Recurrent Prostate Cancer.

Clinical trial NCT06202248 · RECRUITING

Trial details

NCT number: NCT06202248
Sponsor: Alpha Tau Medical LTD.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Non-metastatic Prostate Cancer Locally Recurrent Prostate Cancer

Start date: 2024-03-12
Primary completion: 2027-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.